Related Posts
- Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity
Background Although immune checkpoint inhibitors have been a breakthrough in clinical oncology, these therapies fail…
- PD-L1 Expression Predicts Efficacy of PD-1/PD-L1 Inhibitors in Metastatic TNBC
KEY TAKEAWAYS The phase 3 IMPassion131 trial aimed to analyze the prognostic significance of PD-L1…
- PD-L1 Expression in PTC Following CLLT
KEY TAKEAWAYS The study aimed to investigate PD-L1 in PTC, assessing its prognostic significance and…